CDCA - China Factory, Suppliers, Manufacturers

CDCA, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%
Read More

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

L-Menthol CAS 2216-51-5 Purity >99.5% (GC) Factory

tert-Butylhydroquinone (TBHQ) CAS 1948-33-0 Purity >99.5% (GC) Food Antioxidant Factory

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

Top Selling Products

Related Blog
Reviews

Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

Focus on Cross Border Integration of Biomedicine and Chemical Materials: New Opportunities, New Technologies and New Models This forum focuses on the interdisciplinary and cutting-edge technologies...
Xi presents award to top scientists

President Xi Jinping, also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, presents China’s top science award to a...
Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...
The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

The 3rd CMC-China 2021 Time: September 29-30, 2021 Exhibition Venue: C-D Hall, Suzhou International Expo Center, Suzhou City, JIangsu Province, China. Synergy of Centralized China’s Drug Volume-ba...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Eqiupment: GC instrument (Shimadzu GC-2010) Column: DB-17 Agilent 30mX0.53mmX1.0μm Initial oven temperature: 80℃ Initial time 2.0min Rate ...

2022.12.27 11:58:20
2022.12.21 20:54:46
2022.09.21 09:15:28
2022.07.10 19:51:55
2022.05.31 14:14:18
2021.11.18 12:45:21

CDCA - China Factory, Suppliers, Manufacturers

Related Products

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

L-Menthol CAS 2216-51-5 Purity >99.5% (GC) Factory

tert-Butylhydroquinone (TBHQ) CAS 1948-33-0 Purity >99.5% (GC) Food Antioxidant Factory

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

Top Selling Products

2-Amino-4'-Bromobenzophenone CAS 1140-17-6 Purity >98.0% (HPLC)

3-Hexenedinitrile (DCB) CAS 1119-85-3 Purity >98.0% (GC) Lithium Battery Electrolyte Additive

H-β-Ala-OEt·HCl CAS 4244-84-2 β-Alanine Ethyl Ester Hydrochloride Purity >98.0% (Titration)

(S)-1-Boc-Piperazine-2-Carboxylic Acid CAS 159532-59-9 Purity ≥98.0% High Purity

(S)-1-Cbz-Pyrrolidine-3-Carboxylic Acid CAS 192214-00-9 Purity >99.0% (HPLC)

Z-β-Ala-OH CAS 2304-94-1 N-Cbz-β-Alanine Purity >98.5% (HPLC) Factory

Ethyl 4-Nitrophenylacetate CAS 5445-26-1 Purity ≥98.0% (HPLC) Factory

Sodium Acetate Trihydrate CAS 6131-90-4 Purity >99.5% (Titration) Buffer Ultrapure Factory

Boc-Lys(2-Cl-Z)-OH CAS 54613-99-9 Purity >99.0% (HPLC) Factory

Bis(2,6-Diisopropylphenyl)carbodiimide CAS 2162-74-5 (Stabilizer 7000) Purity >98.0% (GC)

Boc-Arg(Z)-OH CAS 51219-18-2 Purity >98.0% (HPLC)

N-Acetyl-L-Phenylalanine CAS 2018-61-3 (Ac-Phe-OH) Purity >99.0% (HPLC) Factory

Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

Xi presents award to top scientists

Paxlovid: what we know about Pfizer's Covid-19 pill

The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

2022.12.27 11:58:20

2022.12.21 20:54:46

2022.09.21 09:15:28

2022.07.10 19:51:55

2022.05.31 14:14:18

2021.11.18 12:45:21

related search